Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK - Supplementary material

  • László Szilberhorn (Contributor)
  • Tamás Zelei (Contributor)
  • Heleen Vellekoop (Creator)
  • Simone Huygens (Creator)
  • Matthijs Versteegh (Creator)
  • Maureen van Molken (Contributor)
  • Rositsa Koleva-Kolarova (Creator)
  • Apostolos Tsiachristas (University of Oxford) (Creator)
  • Sarah Wordsworth (Creator)
  • Balázs Nagy (Creator)

Dataset

Description

Appendix Table 1 Age and sex specific mortality rates and population utility in the Netherlands and United Kingdom
Date made available2023
PublisherFuture Science Group

Cite this